I assume 10mg/kg in combination with Dacarbazine will be approved also.
Why? What would be the motivation for BMY to submit that sBLA given the broad label just given to them?
Unless otherwise indicated, this is the personal viewpoint of David Miller and not necessarily that of Biotech Stock Research, LLC. We're on Twitter at BiotechStockRsr